Teder H, Erichsen C, Christensson P I, Jönsson P E, Stenram U
Department of Surgery, Helsingborgs Lasarett, Sweden.
Cancer Drug Deliv. 1987;4(3):169-76. doi: 10.1089/cdd.1987.4.169.
The effect of degradable starch microspheres (DSM) on the cellular incorporation of 5-fluorouracil (FUra) was studied in rats with solitary liver tumours. 3H-labelled FUra [0.78 mg (6000 nmol)/kg b.wt.] was injected with saline or mixed with DSM, into the hepatic artery. Labelling of the acid soluble fraction (ASF), RNA and DNA of tumour, liver, bone marrow and small intestine was measured 60 minutes after injection. The DSM had no significant effect on the incorporation of FUra into the ASF or RNA, neither in tumour nor liver tissue. Regarding the tumour/normal tissue ratios of specific radioactivities, there was with DSM a higher tumour/liver and a higher tumour/bone marrow ratio in the ASF, indicating an increased tumour drug exposure with DSM. However, this was not accompanied by any significant increase in drug anabolism.
在患有孤立性肝肿瘤的大鼠中,研究了可降解淀粉微球(DSM)对5-氟尿嘧啶(FUra)细胞摄取的影响。将3H标记的FUra[0.78毫克(6000纳摩尔)/千克体重]与生理盐水混合或与DSM混合后注入肝动脉。注射后60分钟测量肿瘤、肝脏、骨髓和小肠的酸溶性部分(ASF)、RNA和DNA的标记情况。DSM对FUra在肿瘤和肝脏组织中进入ASF或RNA的摄取没有显著影响。关于比放射性的肿瘤/正常组织比率,在ASF中,使用DSM时肿瘤/肝脏和肿瘤/骨髓的比率更高,表明使用DSM时肿瘤药物暴露增加。然而,这并未伴随药物合成代谢的任何显著增加。